Suggestions
Matt Schwartz
Co-founder and CEO @ Afresh
Matt Schwartz is the CEO and Co-Founder of Virgo, a company dedicated to revolutionizing endoscopy with innovative data capture solutions, workflow automation tools, and AI-based precision pharma models.
He is a highly accomplished biomedical engineer and medtech product expert, leading Virgo to collect the largest dataset of endoscopy videos globally, with over 1 million procedures to date and continuously expanding.
Matt Schwartz's educational background includes a B.E. in Biomedical Engineering and Engineering Management from Vanderbilt University, where he also pursued studies in Bioengineering and Biomedical Engineering at the undergraduate level.
Prior to his current role, Matt held key positions in the industry, serving as the CEO & Co-founder of Virgo Surgical Video Solutions, Inc., a Board Member at Techstars Bay Area Chapter, and Product Manager at prominent companies such as Intuitive Surgical and NuVasive.
Beyond his professional endeavors, Matt Schwartz showcases diverse interests in Artificial Intelligence, Photography, Astronomy, Astrophotography, and Ping Pong, adding depth to his multifaceted personality.
Highlights
Great time at #DDW2024 🎉 Top 3 highlights were:
-
Seeing Virgo's own Safia Speer present a poster on the early results of our AI-assisted IBD trial recruitment workflow. Awesome job, Safia — can't wait to watch how this research evolves!
-
Catching up with and meeting so many folks who are excited about the current and future state of AI in gastroenterology. We are finally evolving beyond just CADe and CADx for polyps....there's unlimited potential for applied AI.
-
The Alimentiv IBD party. What a fun celebration of the global IBD community and the perfect way to wrap up another successful DDW!
Look forward to seeing everyone next year here in San Diego ☀ 😎
Make sure to find Safia Speer tomorrow (Sunday 5/19 12:30pm-1:30pm) during the American Gastroenterological Association (AGA) AI & ML poster session!
Safia will be presenting our early results of using an AI-assisted workflow to accelerate patient recruitment in IBD clinical trials. Poster number = Su1980
Enrollment is a massive challenge for IBD trials and significantly delays bringing new treatment options to patients. In theory, there are more than enough patients to enroll trials quickly. The challenge is finding patients in the right location and at the right time. AI can help solve this problem when properly incorporated into patient recruitment workflows.
Come learn more and help us build the future of rapid trial enrollment!
#DDW2024 #IBD #clinicaltrials #AI #digitalhealth
